Wolff Wiese Magana’s Teva Pharmaceuticals TEVA Stock Holding History

Wolff Wiese Magana’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86K	Hold	55	–	–	﹤0.01%	833
2026 Q1	$1.66K	Hold	55	–	–	﹤0.01%	807
2025 Q4	$1.72K	Hold	55	–	–	﹤0.01%	769
2025 Q3	$1.11K	Hold	55	–	–	﹤0.01%	840
2025 Q2	$922	Hold	55	–	–	﹤0.01%	852
2025 Q1	$846	Hold	55	–	–	﹤0.01%	873
2024 Q4	$1.21K	Hold	55	–	–	﹤0.01%	787
2024 Q3	$992	Hold	55	–	–	﹤0.01%	857
2024 Q2	$894	Hold	55	–	–	﹤0.01%	645
2024 Q1	$777	Hold	55	–	–	﹤0.01%	596
2023 Q4	$575	Hold	55	–	–	﹤0.01%	614
2023 Q3	$561	Hold	55	–	–	﹤0.01%	680
2023 Q2	$415	Hold	55	–	–	﹤0.01%	710
2023 Q1	$487	Hold	55	–	–	﹤0.01%	649
2022 Q4	$502	Hold	55	–	–	﹤0.01%	643
2022 Q3	$0	Hold	55	–	–	﹤0.01%	968
2022 Q2	$0	Hold	55	–	–	﹤0.01%	969
2022 Q1	$1K	Hold	55	–	–	﹤0.01%	787
2021 Q4	$0	Hold	55	–	–	﹤0.01%	856
2021 Q3	$1K	Hold	55	–	–	﹤0.01%	786
2021 Q2	$1K	Hold	55	–	–	﹤0.01%	809
2021 Q1	$1K	Hold	55	–	–	﹤0.01%	717
2020 Q4	$1K	Buy	+55	New	+$527	﹤0.01%	665

Other funds holding TEVA

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

BCM

Bourgeon Capital Management Darien, Connecticut $679M AUM 50.89% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wolff Wiese Magana's TEVA Position: Q2 2026 in Review

Wolff Wiese Magana held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 55 shares worth $1.86K. The position accounts for ﹤0.01% of the portfolio, ranked #833.

Wolff Wiese Magana first reported a position in TEVA in Q4 2020 and has held it in 23 quarters since. 141 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Wolff Wiese Magana held 55 shares of Teva Pharmaceuticals worth $1.86K as of Q2 2026.
Wolff Wiese Magana left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #833 holding.
Wolff Wiese Magana first reported a position in Teva Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
141 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.